HORSHAM, Pa., Nov. 13, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its financial results for the quarter ended September 30, 2024 and provides a corporate update. Third Quarter 2024 Highlights Revenue in the third quarter of 2024 was $8.8 million (-1% YOY) vs. $8.9 million in the third quarter of 2 ...

HORSHAM, Pa., Nov. 11, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that the United States District Court for the Eastern District of Pennsylvania entered a court order in favor of the Company in its complaint against LaserOptek America Corp. (“LaserOptek”), Monarch Aesthetic Services, Inc. d/b/a Mo ...

HORSHAM, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report third quarter 2024 financial results on Wednesday, November 13, 2024 after the market close. STRATA management will host a conference call at 4:30 p.m. ET on Wednesday, November 13, 2024 to review financial resul ...

HORSHAM, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that JMEC Co., Ltd., its longstanding Japanese strategic partner and distributor, sponsored a seminar with two lectures on XTRAC® excimer devices on Saturday, October 12, 2024, at the 75th Annual Meeting of the Chubu Branch of the J ...

Group 1 - STRATA Skin Sciences, Inc. is participating in the 2024 Maxim Healthcare Virtual Summit, with President and CEO Dr. Dolev Rafaeli scheduled for a fireside chat [1][2] - The conference will take place virtually from October 15 to 17, 2024, and Dr. Rafaeli will be available for one-on-one meetings with registered investors [2] - STRATA specializes in developing and marketing innovative products for dermatologic conditions, including psoriasis, vitiligo, and acne [3] Group 2 - The company's product offerings include the XTRAC® excimer laser, VTRAC® lamp systems, and the TheraClear®X Acne Therapy System [3] - STRATA employs a unique Partnership Program that includes a fee per treatment cost structure, installation, training, and marketing support [4]

HORSHAM, Pa., Sept. 17, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that President and CEO Dr. Dolev Rafaeli will present a corporate overview at the iAccess Alpha - Buyside Best Ideas Fall Conference 2024. The conference is being held virtually from September 24 – 25, 2024. Presentation Date: Sept ...

Core Viewpoint - Momentum investing focuses on "buying high and selling higher" rather than traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Strategy - Momentum investors often face challenges in determining the right entry point for fast-moving stocks, which can lead to limited upside or downside risks [2] - A safer approach involves investing in bargain stocks that exhibit recent price momentum, utilizing tools like the Zacks Momentum Style Score to identify potential candidates [3] Group 2: Strata Skin Sciences, Inc. (SSKN) Analysis - Strata Skin Sciences, Inc. (SSKN) has shown a four-week price change of 2.5%, indicating growing investor interest [4] - The stock has gained 1.7% over the past 12 weeks and has a beta of 1.37, suggesting it moves 37% more than the market [5] - SSKN has a Momentum Score of A, indicating a favorable time to invest based on momentum [6] - The stock has a Zacks Rank 2 (Buy) due to upward trends in earnings estimate revisions, which attract more investors [7] - SSKN is trading at a Price-to-Sales ratio of 0.39, suggesting it is undervalued at 39 cents for each dollar of sales [7] Group 3: Investment Opportunities - SSKN appears to have significant growth potential and is part of a broader list of stocks that meet the 'Fast-Paced Momentum at a Bargain' criteria [8] - Investors can explore over 45 Zacks Premium Screens tailored to different investing styles to identify winning stock picks [9]

Core Insights - STRATA Skin Sciences, Inc. will participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth Conference on September 12, 2024, in New York City, with President and CEO Dr. Dolev Rafaeli attending [1] - The company will conduct one-on-one investor meetings during the conference, providing opportunities for direct engagement with potential investors [2] Company Overview - STRATA Skin Sciences is focused on developing, commercializing, and marketing innovative products for treating dermatologic conditions, including psoriasis, vitiligo, and acne [3] - The company's product offerings include the XTRAC® excimer laser, VTRAC® lamp systems, and the TheraClear®X Acne Therapy System [3] Partnership Program - STRATA operates a unique Partnership Program in the U.S., which features a fee per treatment cost structure instead of requiring equipment purchases [4] - The program includes installation and use of devices, on-site training for personnel, service and maintenance, dedicated account support, and co-op advertising to promote awareness [4]

Exhibit 99.1 STRATA Skin Sciences Reports Second Quarter 2024 Financial Results and Provides a Corporate Update HORSHAM, Penn., August 14, 2024 – STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its financial results for the quarter ended June 30, 2024 and provides a corporate update. Second Quarter 2024 Highlights • Revenue in ...

HORSHAM, Pa., Aug. 07, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report second quarter 2024 financial results on Wednesday, August 14, 2024 after the market close. STRATA management will host a conference call at 4:30 p.m. ET on Wednesday, August 14, 2024 to review financial results ...